Oncosec Medical Incorporated (ONCS) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jan 31 2023 to Jan 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncosec Medical Incorporated  (NASDAQ: ONCS)


Oncosec Medical Incorporated's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Oncosec Medical Incorporated's ROA in the second quarter of 2023?
Oncosec Medical Incorporated recorded a cumulative net loss of $-29 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -183.82%.

However, within the Healthcare sector 1192 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2023 from 5380 to 6170.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jan 31 2023)
II. Quarter		 (Oct 31 2022)
I. Quarter		 (Jul 31 2022)
IV. Quarter		 (Apr 30 2022)
III. Quarter		 (Jan 31 2022)
II. Quarter
Y / Y Total Assets Change -71.76 % -69.22 % -64.63 % -60.5 % -52.98 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -29 -32 -34 -38 -41
Return On Assets (TTM) -183.82 % -150 % -118.32 % -101.01 % -88.26 %
ONCS's Total Ranking # 6170 # 5380 # 5410 # 5289 # 5586
Total Assets (TTM) in million 9 13 19 24 31
Seq. Total Assets Change -31.38 % -30.46 % -21.08 % -25.01 % -25.2 %
Seq. Net Income Change - - - - -

ONCS's 5 Years Annual ROA >> Back to ONCS Management Effectiveness >> Compare ONCS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 582
Sector # 1193
Overall # 5964

Return On Assets Statistics
High Average Low
-46.51 %
-103.44 %
-160.62 %
(Oct 31 2014)   (Jan 31 2023)





Financial Statements
Oncosec Medical Incorporated's Assets $ 9 million ONCS's Balance sheet
Oncosec Medical Incorporated's Income $ -7 million Quarterly ONCS's Income Statement
ONCS's Income by Division See ONCS's Income by Division



Annual Return On Assets (Jul 31 2022)
FY 2022		 (Jul 31 2021)
FY 2021		 (Jul 31 2020)
FY 2020		 (Jul 31 2019)
FY 2019		 (Jul 31 2018)
FY 2018
Y / Y Total Assets Change -64.63 % 105.01 % -14.24 % -1.17 % 98.56 %
Total Assets in million 19 53 26 30 30
Y / Y Net Income Change - - - - -
Net Income in million -34 -45 -42 -30 -39
Annual Return On Assets -183.86 % -85.94 % -164.82 % -101.28 % -129.39 %

ONCS's 5 Years Annual ROA >> Back to ONCS Management Effectiveness >> Compare ONCS ROA to its Competitors



More Return On Assets Ratios
ONCS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ONCS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ONCS's Competitors
Subscribers only: Roa for Oncosec Medical Incorporated's Suppliers
Subscribers only: Return On Assets for ONCS's Customers

You may also want to know
ONCS's Roi ONCS's Inventory Turnover Ratio ONCS's Growth Rates ONCS's Dividend Comparisons
ONCS's Profitability Ratios ONCS's Asset Turnover Ratio ONCS's Dividend Growth
ONCS's Roe ONCS's Valuation Ratios ONCS's Financial Strength Ratios ONCS's Dividend Payout Ratio



Companies with similar Return On Assets at Jan 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:51+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.